# DuPont de Nemours, Inc.: Form 10-Q for the period ended Mar 31, 2019

- Company: [DuPont de Nemours, Inc.](/companies/dd.md) (CIK 1666700)
- Form: 10-Q
- Filed: 2019-05-03
- Accepted by EDGAR: May 3, 2019, 12:04 ET
- Period: 2019-03-31
- Accession: 0001666700-19-000019
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1666700/000166670019000019/dowdupont1q19033119.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1666700/000166670019000019/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-01-01 to 2019-03-31 | $19.65bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2019-01-01 to 2019-03-31 | $14.73bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months, 2019-01-01 to 2019-03-31 | $717.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2019-01-01 to 2019-03-31 | $1.67bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months, 2019-01-01 to 2019-03-31 | $209.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-01-01 to 2019-03-31 | $520.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-01-01 to 2019-03-31 | $0.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-01-01 to 2019-03-31 | $0.23 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-01-01 to 2019-03-31 | 2,259,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2019-01-01 to 2019-03-31 | $26.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2019-01-01 to 2019-03-31 | $1.14bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months, 2019-01-01 to 2019-03-31 | $851.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months, 2019-01-01 to 2019-03-31 | $1.58bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-03-31 | $11.54bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-03-31 | $49.25bn | us-gaap:AssetsCurrent |
| Total assets | at 2019-03-31 | $189.78bn | us-gaap:Assets |
| Current liabilities | at 2019-03-31 | $28.58bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2019-03-31 | $38.98bn | us-gaap:LongTermDebt |
| Shareholders' equity | at 2019-03-31 | $92.44bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 84,189 characters.

Effective August 31, 2017, pursuant to the merger of equals transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 ("Merger Agreement"), The Dow Chemical Company ("Historical Dow") and E. I. du Pont de Nemours and Company ("Historical DuPont") each merged with subsidiaries of DowDuPont Inc. ("DowDuPont" or the "Company") and, as a result, Historical Dow and Historical DuPont became subsidiaries of DowDuPont (the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. Historical Dow was determined to be the accounting acquirer in the Merger. As a result, the historical financial statements of Historical Dow for periods prior to the Merger are considered to be the historical financial statements of DowDuPont.

As discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, DowDuPont previously announced its intent to separate into three, independent, publicly traded companies - one for each of its agriculture, materials science and specialty products businesses (the “Intended Business Separations” and the transactions to accomplish the Intended Business Separations, the “separations”). DowDuPont formed two wholly owned subsidiaries: Dow Inc. ("Dow", formerly known as Dow Holdings Inc.), to serve as a holding company for its materials science business, and Corteva, Inc., to serve as a holding company for its agriculture business. Following the separations, DowDuPont will continue to hold the specialty products business and operate as "DuPont".

Effective as of 5:00 p.m. on April 1, 2019, DowDuPont completed the previously announced separation of its materials science business into a separate and independent public company by way of a distribution of Dow through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, par value $0.01 per share (the “Dow Common Stock”), to holders of the Company’s common stock, par value $0.01 per share (the “DowDuPont Common Stock”), as of the close of business on March 21, 2019 (the “Dow Distribution”). DowDuPont expects to complete the previously announced intended separation of its agriculture business into a separate and independent public company on June 1, 2019 by way of a distribution of Corteva, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Corteva”), through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Corteva’s common stock, par value $0.01 per share, to holders of DowDuPont Common Stock as of a record date to be set by the Company’s Board of Directors (the “Corteva Distribution” and, together with the Dow Distribution, the “Distributions”). Following the Corteva Distribution, DowDuPont will hold the specialty products business and operate as "DuPont". The assets and liabilities and results of operations attributed to the materials science and agriculture businesses are included in the Company's consolidated results as of and for the periods presented herein.

Except as otherwise indicated by the context, the term "Historical Dow" includes Historical Dow and its consolidated subsidiaries, "Historical DuPont" includes Historical DuPont and its consolidated subsidiaries, "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of Historical Dow, and "Dow Silicones" means Dow Silicones Corporation, a wholly owned subsidiary of Historical Dow.

### OVERVIEW

The following is a summary of the results from continuing operations for the three months ended March 31, 2019:

- The Company reported net sales in the first quarter of 2019 of $19.6 billion, down 9 percent from $21.5 billion in the first quarter of 2018, with net sales declines across all geographic regions and segments, except Safety & Construction. These declines were due to a decrease in local price of 4 percent, a 3 percent unfavorable currency impact and a volume decline of 2 percent.
- Local price decreased 4 percent compared with the same period last year, with decreases in all geographic regions and two segments, Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure (both down 11 percent), which were partially offset by increases in Transportation & Advanced Polymers (up 7 percent), Safety & Construction (up 4 percent), Nutrition & Biosciences (up 2 percent) and Agriculture (up 1 percent). Performance Materials & Coatings and Electronics & Imaging were both flat.
- Currency had an unfavorable impact of 3 percent on sales, driven primarily by Europe, Middle East and Africa ("EMEA").
- Volume decreased 2 percent compared with the first quarter of 2018, with decreases in all operating segments, except Industrial Intermediates & Infrastructure (up 6 percent), Safety & Construction (up 4 percent) and Performance Materials & Coatings (up 1 percent). Volume decreased in U.S. & Canada (down 7 percent) and Latin America (down 1 percent), and increased in Asia Pacific (up 3 percent) and EMEA (up 1 percent).
- Research and development ("R&D") expenses totaled $717 million in the first quarter of 2019, down from $768 million in the first quarter of 2018. Selling, general and administrative ("SG&A") expenses were $1,672 million in the first quarter of 2019, down from $1,714 million in the first quarter of 2018. R&D and SG&A expenses decreased primarily due to synergies.
- Restructuring and asset related charges - net were $287 million in the first quarter of 2019, primarily reflecting post-merger restructuring actions under the DowDuPont Cost Synergy Program of $280 million.
- Integration and separation costs were $813 million in the first quarter of 2019, up from $457 million in the first quarter of 2018, reflecting post-Merger integration and Intended Business Separation activities.
- Equity in earnings of nonconsolidated affiliates was $26 million in the first quarter of 2019, down from $257 million in the first quarter of 2018, primarily due to increased equity losses from Sadara and lower equity earnings from the Kuwait joint ventures (due to lower monoethylene glycol prices), the Thai joint ventures and the HSC Group.
- Sundry income (expense) - net was income of $248 million in the first quarter of 2019, up from income of $115 million in the first quarter of 2018, primarily due to a decrease in foreign exchange losses.
- Net income available for common stockholders was $520 million ($0.23 per share) in the first quarter of 2019, compared with $1,104 million ($0.47 per share) in the first quarter of 2018.
- On February 14, 2019, the Company announced that its Board declared a dividend of $0.38 per share, paid on March 15, 2019, to shareholders of record on February 28, 2019.
- On March 8, 2019, the Company announced that its Board declared a dividend of $325 million ($0.14 per share), payable on May 28, 2019, to shareholders of record on April 26, 2019.

*In millions, except per share amounts*

| Selected Financial Data | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $19,649 | $21,510 |
| Cost of sales ("COS") | $14,726 | $16,315 |
| Percent of net sales | 74.9% | 75.8% |
| Research and development expenses | $717 | $768 |
| Percent of net sales | 3.6% | 3.6% |
| Selling, general and administrative expenses | $1,672 | $1,714 |
| Percent of net sales | 8.5% | 8.0% |
| Effective tax rate | 26.8% | 25.2% |
| Net income available for common stockholders | $520 | $1,104 |
| Earnings per common share – basic | $0.23 | $0.47 |
| Earnings per common share – diluted | $0.23 | $0.47 |

In addition to the financial highlights above, the following events occurred subsequent to the first quarter of 2019:

- On April 3, 2019, the Company's Board of Directors approved a reverse stock split of the Company’s common stock, subject to stockholder approval which will be determined during a special meeting of stockholders scheduled for May 23, 2019. If stockholders approve the reverse stock split, the Board of Directors will select a reverse stock split ratio of not less than 2-for-5 and not greater than 1-for-3, with an exact ratio as may be determined by the Board of Directors at a later date so that, depending on the ratio chosen, stockholders’ shares of issued and outstanding common stock will be converted at a ratio between (i) two shares of issued and outstanding common stock for every five shares of common stock owned and (ii) one share of issued and outstanding common stock for every three shares of common stock owned. The price of each common

share is expected to increase so that a stockholder would have fewer but higher priced shares. A reverse stock split would not have any impact on the voting and other rights of stockholders and will have no impact on the Company’s business operations or any of its outstanding indebtedness. If approved, the Company expects to implement the reverse stock split effective immediately following the Corteva Distribution. Even if the reverse stock split is approved by the Company’s stockholders, the Board of Directors may delay or abandon the reverse stock split at any time prior to the effective time of the reverse stock split if the Board of Directors determines that the reverse stock split is no longer in the best interests of the Company or its stockholders.

- On May 2, 2019, in anticipation of becoming an independent, specialty products company following the intended Corteva Distribution, DowDuPont announced changes to its management and reporting structure resulting in the creation of a new Non-Core segment ("Second Quarter Segment Realignments").

These changes result in the following being realigned to Non-Core:

- Photovoltaic and Advanced Materials business unit (including the HSC Group joint ventures: DC HSC Holdings LLC and Hemlock Semiconductor L.L.C) from the Electronics & Imaging segment;
- Biomaterials and Clean Technologies business units from the Nutrition & Biosciences segment;
- DuPont Teijin Films joint venture from the Transportation & Advanced Polymers segment; and
- Sustainable Solutions business unit from the Safety & Construction segment.

In addition, the following changes will occur:

- Consolidation of the Nutrition & Health business with the Industrial Biosciences business within the Nutrition & Biosciences reportable segment. Previously, Nutrition & Health and Industrial Biosciences were separate operating segments which did not meet the quantitative thresholds.
- Pre-commercial activities related to the Biomaterials business unit will be realigned from Corporate to Non-Core, with the remaining pre-commercial activities realigned to the Nutrition & Biosciences segment.

The changes become effective June 1, 2019 and the Company will report financial results under this new structure beginning in the second quarter of 2019.

### RESULTS OF OPERATIONS

*In millions*

| Summary of Sales Results | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $19,649 | $21,510 |

The following table summarizes sales variances by segment and geographic region from the prior year:

*Sales Variances by Segment and Geographic Region*

| Percentage change from prior year | Three Months Ended Mar 31, 2019 Local Price & Product Mix | Currency | Volume | Portfolio & Other | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Agriculture | 1% | (5)% | (7)% | —% | (11)% |
| Performance Materials & Coatings | — | (3) | 1 | — | (2) |
| Industrial Intermediates & Infrastructure | (11) | (3) | 6 | — | (8) |
| Packaging & Specialty Plastics | (11) | (2) | (2) | — | (15) |
| Electronics & Imaging | — | (1) | (6) | — | (7) |
| Nutrition & Biosciences | 2 | (3) | (2) | (1) | (4) |
| Transportation & Advanced Polymers | 7 | (3) | (9) | — | (5) |
| Safety & Construction | 4 | (2) | 4 | (4) | 2 |
| Total | (4)% | (3)% | (2)% | —% | (9)% |
| U.S. & Canada | (4)% | —% | (7)% | —% | (11)% |
| EMEA 1 | (3) | (6) | 1 | (1) | (9) |
| Asia Pacific | (4) | (2) | 3 | — | (3) |
| Latin America | (6) | (2) | (1) | — | (9) |
| Total | (4)% | (3)% | (2)% | —% | (9)% |

1\. Europe, Middle East and Africa.

The Company reported net sales in the first quarter of 2019 of $19.6 billion, down 9 percent from $21.5 billion in the first quarter of 2018, primarily due to decreased selling prices, negative currency impact and lower demand. Sales declines were broad-based with decreases in most segments and all geographic regions. Local price was down 4 percent compared with the same period last year as decreases in Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure (both down 11 percent) more than offset increases in Transportation & Advanced Polymers (up 7 percent), Safety & Construction (up 4 percent), Nutrition & Biosciences (up 2 percent) and Agriculture (up 1 percent). Performance Materials & Coatings and Electronics & Imaging were both flat. Local price decreased in all geographic regions. Currency unfavorably impacted sales 3 percent compared with the same period last year, driven primarily by EMEA (down 6 percent). Volume decreased 2 percent as decreases in Transportation & Advanced Polymers (down 9 percent), Agriculture (down 7 percent), Electronics & Imaging (down 6 percent) and Packaging & Specialty Plastics and Nutrition & Biosciences (both down 2 percent) more than offset gains in Industrial Intermediates & Infrastructure (up 6 percent), Safety & Construction (up 4 percent) and Performance Materials & Coatings (up 1 percent). Volume decreased in U.S. & Canada (down 7 percent) and Latin America (down 1 percent), and increased in Asia Pacific (up 3 percent) and EMEA (up 1 percent). Portfolio & Other was flat.

### Cost of Sales

Cost of sales was $14.7 billion in the first quarter of 2019, down from $16.3 billion in the first quarter of 2018. Cost of sales decreased in the first quarter of 2019 primarily due to lower sales volume, lower feedstock and other raw material costs, decreased planned maintenance turnaround costs, lower commissioning expenses related to U.S. Gulf Coast growth projects and cost synergies. Cost of sales in the first quarter of 2018 was negatively impacted by a $703 million charge for the fair value step-up in Historical DuPont's inventories as a result of the Merger and the acquisition of the H&N Business, related to Agriculture ($639 million), Nutrition & Biosciences ($63 million) and Safety & Construction ($1 million); compared with a $205 million charge during the first quarter of 2019 related to Agriculture.

Cost of Sales as a percentage of net sales in the first quarter of 2019 was 74.9 percent compared with 75.8 percent in the same period last year.

### Research and Development Expenses

R&D expenses totaled $717 million in the first quarter of 2019, down from $768 million in the first quarter of 2018. R&D expenses decreased primarily due to synergies.

### Selling, General and Administrative Expenses

SG&A expenses were $1,672 million in the first quarter of 2019, down from $1,714 million in the first quarter of 2018. SG&A expenses decreased primarily due to synergies.

### Amortization of Intangibles

Amortization of intangibles was $474 million in the first quarter of 2019 and 2018. See Note 11 to the Consolidated Financial Statements for additional information on intangible assets.

### Restructuring and Asset Related Charges - Net

Restructuring and asset related charges - net were $287 million in the first quarter of 2019, up from $262 million in the first quarter of 2018 and consisted primarily of the following:

#### DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), which is designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations. The Company expects to record total pretax restructuring charges of approximately $2.2 billion of which $2.0 billion has been recorded inception-to-date.

For the three months ended March 31, 2019 and 2018, the Company recorded pretax restructuring charges of $280 million and $260 million, respectively. The charge for the three months ended March 31, 2019 consisted of severance and related benefit costs of $112 million, asset write-downs and write-offs of $116 million and costs associated with exit and disposal activities of $52 million. The charge for the three months ended March 31, 2018 consisted of severance and related benefit costs of $172 million, asset write-downs and write-offs of $48 million and costs associated with exit and disposal activities of $40 million. The impact of these charges is shown as "Restructuring and asset related charges - net" in the consolidated statements of income. The Company expects to substantially complete the Synergy Program by the end of 2019.

The restructuring charges for the three months ended March 31, 2019 were related to each segment as follows: $47 million in Agriculture, $28 million in Nutrition & Biosciences, $2 million in Safety & Construction, $1 million in Packaging & Specialty Plastics, $1 million in Transportation & Advanced Polymer and $201 million in Corporate.

#### DowDuPont Agriculture Division Restructuring Program

During the fourth quarter of 2018 and in connection with the ongoing integration activities, DowDuPont approved restructuring actions to simplify and optimize certain organizational structures within the Agriculture segment in preparation for the Intended Business Separations ("Agriculture Division Program"). As a result of these actions, the Company expects to record total pretax charges of approximately $96 million, comprised of $83 million of severance and related benefit costs, $11 million of asset write-downs and write-offs and $2 million of costs associated with exit and disposal activities. The Company has recorded restructuring charges of $83 million inception-to-date under the Agriculture Division Program.

For the three months ended March 31, 2019, DowDuPont recorded a net pretax restructuring benefit of $1 million, consisting of a favorable adjustment of $4 million to the severance and related benefit costs reserve and asset write-downs and write-offs of $3 million. The impact of these items was shown as "Restructuring and asset related charges - net" in the consolidated statements of income. The Company expects actions related to the Agriculture Division Program to be substantially complete by mid 2019.

Restructuring adjustments recorded for severance and related benefit costs and charges recorded for asset write-downs and write‑offs were related to Corporate and Agriculture, respectively.

### Integration and Separation Costs

Integration and separation costs, which reflect costs related to the Merger and the ownership restructure of Dow Silicones, as well as post-Merger integration and Intended Business Separation activities, were $813 million in the first quarter of 2019, up from $457 million in the first quarter of 2018. Integration and separation costs are related to the Corporate segment.

### Equity in Earnings of Nonconsolidated Affiliates

The Company's share of the earnings of nonconsolidated affiliates was $26 million in the first quarter of 2019, down from $257 million in the first quarter of 2018, primarily due to increased equity losses from Sadara and lower equity earnings from the Kuwait joint ventures (due to lower monoethylene glycol and polyethylene prices), the Thai joint ventures and the HSC Group.

### Sundry Income (Expense) - Net

Sundry income (expense) – net includes a variety of income and expense items such as foreign currency exchange gains or losses, interest income, dividends from investments, gains and losses on sales of investments and assets, non-operating pension and other postretirement benefit plan credits or costs, and certain litigation matters. Sundry income (expense) – net in the first quarter of 2019 was income of $248 million, compared with income of $115 million in the first quarter of 2018. The first quarter of 2019 included income related to non-operating pension and other postretirement benefit plans, interest income and gains on the sale of assets and other investments, which includes a $51 million gain related to an asset sale by Historical DuPont. These gains more than offset a $24 million loss on a Historical Dow divestiture (related to Agriculture) and foreign currency exchange losses.

The first quarter of 2018 included income related to non-operating pension and other postretirement benefit plans, interest income and a $20 million gain for post-closing adjustments on Historical Dow's sale of its equity interest in MEGlobal (related to Industrial Intermediates & Infrastructure). These gains more than offset foreign currency exchange losses, which included a $50 million foreign exchange loss related to adjustments to foreign currency exchange contracts for the change in the U.S. tax rate (related to Corporate). See Notes 6 and 18 to the Consolidated Financial Statements for additional information.

### Interest Expense and Amortization of Debt Discount

Interest expense and amortization of debt discount was $454 million in the first quarter of 2019, up from $350 million in the first quarter of 2018. The increase primarily relates to higher debt balances as a result of DowDuPont debt issued in the fourth quarter of 2018. See Note 13 to the Consolidated Financial Statements and the discussion of the DowDuPont Notes in Changes in Financial Condition in Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations for additional information.

### Provision for Income Taxes on Continuing Operations

The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings. The effective tax rate for the first quarter of 2019 was 26.8 percent, compared to 25.2 percent for the first quarter of 2018.

The tax rate in the first quarter of 2019 was unfavorably impacted by non-tax-deductible amortization of the fair value step-up in Historical DuPont’s inventories as a result of the Merger as well as non-deductible restructuring costs and tax impacts related to spin preparation activities. The tax rate was favorably impacted by net tax benefits related to the issuance of stock-based compensation as well as deferred tax remeasurement in foreign jurisdictions.

The tax rate in the first quarter of 2018 was unfavorably impacted by certain integration, separation and restructuring costs associated with the Intended Business Separations as well as non-deductible amortization of the fair value step-up in Historical DuPont’s inventories as a result of the Merger, partially offset by the tax benefits related to the issuance of stock-based compensation.

### Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $51 million in the first quarter of 2019, up from $44 million in the first quarter of 2018.

### Net Income Available for DowDuPont Inc. Common Stockholders

Net income available for common stockholders was $520 million, or $0.23 per share, in the first quarter of 2019, compared with $1,104 million, or $0.47 per share, in the first quarter of 2018. See Note 8 to the Consolidated Financial Statements for details on the Company's earnings per share calculations.

### SEGMENT RESULTS

The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., “Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of significant items. Reconciliations of these measures can be found in Note 23 to the Consolidated Financial Statements.

### AGRICULTURE

The Agriculture segment leverages the Company’s technology, customer relationships and industry knowledge to improve the quantity, quality and safety of the global food supply and the global production agriculture industry. Land available for worldwide agricultural production is increasingly limited so production growth will need to be achieved principally through improving crop yields and productivity. The segment’s two global businesses, Seed and Crop Protection, deliver a broad portfolio of products and services that are specifically targeted to achieve gains in crop yields and productivity, including well-established brands of seed products, crop chemicals, seed treatment, agronomy and digital services. R&D focuses on leveraging germplasm and plant science technology to increase farmer productivity and to enhance the value of grains and oilseeds through improved seed traits, superior seed germplasm and effective use of crop protection solutions.

*In millions*

| Agriculture | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $3,397 | $3,808 |
| Operating EBITDA | $667 | $891 |
| Equity losses | $— | $(1) |

| Agriculture Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2019 |
| --- | ---: |
| Local price & product mix | 1% |
| Currency | (5) |
| Volume | (7) |
| Portfolio & other | — |
| Total | (11)% |

Agriculture net sales were $3,397 million in the first quarter of 2019, down 11 percent from $3,808 million in the first quarter of 2018. The decrease was primarily due to a 7 percent decline in volume and a 5 percent decline in currency, partially offset by a 1 percent increase in local price.

The decline in volume was driven by weather related delays and flooding in the U.S. which impacted both Seed and Crop Protection, a change in the route to market in the Pacific Northwest, which delayed sales recognition to the second quarter, and early deliveries of seed in the fourth quarter of 2018. These declines were partially offset by favorable demand and weather conditions leading to a strong corn season in EMEA and strong demand for insecticides in Latin America and EMEA.

Unfavorable currency impacts due to the Euro, other Eastern European currencies, and the Brazilian Real were partially offset by increases in local price in Crop Protection to offset currency pressure, as well as price gains in EMEA due to changes in route to market.

Operating EBITDA was $667 million in the first quarter of 2019, compared with $891 million in the same quarter last year. Volume declines primarily driven by weather related delays in the U.S., higher input costs, and the unfavorable impact of currency were partially offset by cost synergies.

### PERFORMANCE MATERIALS & COATINGS

Performance Materials & Coatings includes industry-leading franchises that deliver a wide array of solutions into consumer and infrastructure end-markets. The segment consists of two global businesses: Coatings & Performance Monomers and Consumer Solutions. These businesses primarily utilize the Company's acrylics-, cellulosics- and silicone-based technology platforms to serve the needs of the architectural and industrial coatings, home care and personal care end-markets. Both businesses employ materials science capabilities, global reach and unique products and technology to combine chemistry platforms to deliver differentiated offerings to customers.

*In millions*

| Performance Materials & Coatings | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $2,255 | $2,304 |
| Operating EBITDA | $481 | $586 |
| Equity earnings | $— | $— |

| Performance Materials & Coatings Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2019 |
| --- | ---: |
| Local price & product mix | —% |
| Currency | (3) |
| Volume | 1 |
| Portfolio & other | — |
| Total | (2)% |

Performance Materials & Coatings net sales were $2,255 million in the first quarter of 2019, down from net sales of $2,304 million in the first quarter of 2018. Net sales decreased 2 percent compared with the first quarter of 2018 driven by currency headwinds, which had an unfavorable impact on sales of 3 percent, which was partially offset by a 1 percent increase in volume. Local price was flat compared with the same quarter last year. Consumer Solutions sales were flat, as volume growth was offset by local price declines in siloxanes, the shedding of low-margin business in home and personal care and the unfavorable impact of currency. Coatings & Performance Monomers sales were down, as volume improvement for vinyl acetate monomer was more than offset by a decline in volume for architectural binders and functional coatings and the unfavorable impact of currency.

Operating EBITDA was $481 million, down 18 percent from Operating EBITDA of $586 million in the first quarter of 2018, primarily due to lower prices for siloxanes and shipping restrictions from a Performance Monomers facility in Deer Park, Texas, due to a fire at a nearby third-party storage and terminal facility, which more than offset lower feedstock and other raw material costs and cost synergies.

### INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE

Industrial Intermediates & Infrastructure consists of two customer-centric global businesses - Industrial Solutions and Polyurethanes & CAV - that develop important intermediate chemicals that are essential to manufacturing processes, as well as downstream, customized materials and formulations that use advanced development technologies. These businesses primarily produce and market ethylene oxide, propylene oxide derivatives, cellulose ethers, redispersible latex powders and acrylic emulsions that are aligned to market segments as diverse as appliances, coatings, infrastructure, oil and gas and building and construction. The global scale and reach of these businesses, world-class technology and R&D capabilities and materials science expertise enable the Company to be a premier solutions provider offering customers value-add sustainable solutions to enhance comfort, energy efficiency, product effectiveness and durability across a wide range of home comfort and appliances, building and construction, adhesives and lubricant applications, among others. This segment also includes a portion of the results of EQUATE Petrochemical Company K.S.C.C. ("EQUATE"), The Kuwait Olefins Company K.S.C.C. ("TKOC"), Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

Historical Dow is responsible for marketing a majority of Sadara products outside of the Middle East zone through Historical Dow's established sales channels. As part of this arrangement, Historical Dow purchases and sells Sadara products for a marketing fee.

*In millions*

| Industrial Intermediates & Infrastructure | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $3,402 | $3,715 |
| Operating EBITDA | $448 | $654 |
| Equity earnings (losses) | $(48) | $149 |

| Industrial Intermediates & Infrastructure Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2019 |
| --- | ---: |
| Local price & product mix | (11)% |
| Currency | (3) |
| Volume | 6 |
| Portfolio & other | — |
| Total | (8)% |

Industrial Intermediates & Infrastructure net sales were $3,402 million in the first quarter of 2019, down from net sales of $3,715 million in the first quarter of 2018. Net sales decreased 8 percent compared with the same quarter last year, with volume up 6 percent, currency down 3 percent and local price down 11 percent. Local price decreased in all geographic regions and all businesses. Local price decreases were primarily driven by price declines in isocyanates. Currency had an unfavorable impact on sales of 3 percent, primarily in EMEA. Volume increased in all geographic regions and all businesses. Polyurethanes & CAV reported volume increases in all geographic regions, with double-digit volume growth in Asia Pacific. Volume growth was driven by increased supply from Sadara and higher demand for propylene glycols and industrial, comfort and energy efficiency products. Industrial Solutions reported volume gains in U.S. & Canada and EMEA, reflecting increased demand for industrial and oil and gas applications as well as strong demand for de-icing fluids, lubricants and fuels, and greater production from Sadara.

Operating EBITDA was $448 million in the first quarter of 2019, down 31 percent compared with Operating EBITDA of $654 million in the first quarter of 2018. Operating EBITDA decreased as the impact of margin compression in isocyanates products, lower equity earnings from the Kuwait joint ventures and increased equity losses from Sadara more than offset lower feedstock and other raw material costs, cost synergies and demand growth.

### PACKAGING & SPECIALTY PLASTICS

Packaging & Specialty Plastics is a world leader in plastics and consists of two highly integrated global businesses: Hydrocarbons & Energy and Packaging and Specialty Plastics. The segment employs the industry’s broadest polyolefin product portfolio, supported by the Company’s proprietary catalyst and manufacturing process technologies, to work at the customer’s design table throughout the value chain to deliver more reliable and durable, higher performing, and more sustainable plastics to customers in food and specialty packaging; industrial and consumer packaging; health and hygiene; caps, closures and pipe applications; consumer durables; and infrastructure. This segment also includes the results of The Kuwait Styrene Company K.S.C.C. and The SCG-Dow Group, as well as a portion of the results of EQUATE, TKOC, Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

Historical Dow is responsible for marketing a majority of Sadara products outside of the Middle East zone through Historical Dow’s established sales channels. As part of this arrangement, Historical Dow purchases and sells Sadara products for a marketing fee.

*In millions*

| Packaging & Specialty Plastics | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $5,110 | $6,010 |
| Operating EBITDA | $993 | $1,301 |
| Equity earnings | $38 | $59 |

| Packaging & Specialty Plastics Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2019 |
| --- | ---: |
| Local price & product mix | (11)% |
| Currency | (2) |
| Volume | (2) |
| Portfolio & other | — |
| Total | (15)% |

Packaging & Specialty Plastics net sales were $5,110 million in the first quarter of 2019, down from net sales of $6,010 million in the first quarter of 2018. Net sales decreased 15 percent compared with the same quarter last year, with local price down 11 percent, volume down 2 percent and currency unfavorably impacting sales 2 percent, primarily in EMEA. Local price decreased in both businesses and across all geographic regions driven by reduced polyethylene prices and lower prices for Hydrocarbons & Energy by-products. Volume decreased across all geographic regions, except Asia Pacific, and in Hydrocarbons & Energy which more than offset volume increases in Packaging and Specialty Plastics. Volume decreased in Hydrocarbons & Energy due to increased internal consumption of ethylene on the U.S. Gulf Coast. In addition, lower volumes of by-products were available for sale due to the use of lighter feedslates. Volume increased in Packaging and Specialty Plastics driven by higher demand in Asia Pacific and EMEA, supported by new capacity adds. Packaging and Specialty Plastics volume growth was driven by increased demand for industrial and consumer packaging, food and specialty packaging and elastomer applications.

Operating EBITDA was $993 million in the first quarter of 2019, down 24 percent from Operating EBITDA of $1,301 million in the first quarter of 2018. Operating EBITDA decreased as the impact of lower selling prices, lower sales volume and reduced equity earnings, driven by lower equity earnings at the Kuwait joint ventures due to lower polyethylene pricing and increased turnaround costs, more than offset lower feedstock and other raw material costs, cost synergies, lower start-up and commissioning costs and decreased planned maintenance turnaround spending.

### ELECTRONICS & IMAGING

The Electronics & Imaging segment is a leading global supplier of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The segment is a leading provider of materials and solutions for the fabrication of semiconductors and integrated circuits, and also provides innovative metallization processes for metal finishing, decorative, and industrial applications. Electronics & Imaging is a leading global supplier of key materials for the manufacturing of photovoltaics and solar cells, including innovative metallization pastes and back sheet materials for the production of solar cells and solar modules and in the advanced printing and packaging graphics industry providing flexographic printing inks, photopolymer plates, and platemaking systems used in digital printing applications for textile, commercial and home-office use. In addition, the segment provides cutting-edge materials for the manufacturing of rigid and flexible displays for liquid crystal displays ("LCD"), advanced-matrix organic light emitting diode ("AMOLED"), and quantum dot ("QD") applications. The segment also includes the Company's share of the results of the HSC Group, a U.S.-based group of companies that manufacture and sell polycrystalline silicon products.

In March 2019, DowDuPont announced plans to invest more than $200 million in its Electronics & Imaging segment to increase capacity for the manufacture of KAPTON® film at its Circleville, Ohio, site due to growing global demand.

*In millions*

| Electronics & Imaging | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $1,078 | $1,153 |
| Operating EBITDA | $385 | $398 |
| Equity earnings | $29 | $48 |

| Electronics & Imaging Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2019 |
| --- | ---: |
| Local price & product mix | —% |
| Currency | (1) |
| Volume | (6) |
| Portfolio & other | — |
| Total | (7)% |

Electronics & Imaging net sales were $1,078 million in the first quarter of 2019, down 7 percent from $1,153 million in the first quarter of 2018. Net sales decreased due to a 6 percent volume decline and a 1 percent unfavorable currency impact, primarily in Asia Pacific and EMEA. Volume growth was driven by increased demand in display technology which was more than offset by volume declines, primarily in interconnect solutions and photovoltaic & advanced materials, due to lower demand for consumer electronics and photovoltaics, mainly in Asia Pacific.

Operating EBITDA was $385 million in the first quarter of 2019, down 3 percent compared with $398 million in the first quarter of 2018. Favorable impacts from an asset sale and cost synergies were more than offset by higher raw material costs, volume declines and lower equity earnings.

### NUTRITION & BIOSCIENCES

Nutrition & Biosciences is an innovation-driven and customer-focused segment that provides solutions for the global food and beverage, dietary supplements, pharma, home and personal care, energy and animal nutrition markets. The segment consists of two operating segments: Nutrition & Health and Industrial Biosciences. The Nutrition & Health business is one of the world's largest producers of specialty ingredients, developing and manufacturing solutions for the global food and beverage, dietary supplements and pharmaceutical excipient markets. The Industrial Biosciences business is an industry pioneer and innovator that works with customers to improve the performance, productivity and sustainability of their products and processes through biotechnology, chemistry and engineering solutions including enzymes, biomaterials, biocides and antimicrobial solutions and process technology.

*In millions*

| Nutrition & Biosciences | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $1,659 | $1,720 |
| Operating EBITDA | $390 | $418 |
| Equity earnings | $4 | $3 |

| Nutrition & Biosciences Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2019 |
| --- | ---: |
| Local price & product mix | 2% |
| Currency | (3) |
| Volume | (2) |
| Portfolio & other | (1) |
| Total | (4)% |

Nutrition & Biosciences net sales were $1,659 million in the first quarter of 2019, down 4 percent from $1,720 million in the first quarter of 2018, due to a 2 percent increase in local price, which was more than offset by a 3 percent unfavorable currency impact, a 2 percent decrease in volume and a 1 percent decrease from portfolio actions. Volume gains in Nutrition & Health were more than offset by volume declines in Industrial Biosciences.Volume gains in Nutrition & Health were led by increased protein solutions and systems and texturants demand. This increase was partially offset by a decrease in probiotics due to higher than historical average sales in the first quarter of 2018. Industrial Biosciences volume declines were primarily the result of on-going challenged conditions in U.S. energy markets negatively impacting demand in bioactives and microbial control.

Operating EBITDA was $390 million in the first quarter of 2019, down 7 percent compared with $418 million in the first quarter of 2018, driven by cost savings which were more than offset by higher raw material costs and unfavorable currency impacts.

### TRANSPORTATION & ADVANCED POLYMERS

Transportation & Advanced Polymers provides high-performance engineering resins, adhesives, lubricants and parts to engineers and designers in the transportation, electronics, healthcare, industrial and consumer end-markets to enable systems solutions for demanding applications and environments. The segment delivers a broad range of polymer-based high-performance materials in its product portfolio, including elastomers and thermoplastic and thermoset engineering polymers which are used by customers to fabricate components for mechanical, chemical and electrical systems. In addition, the segment produces innovative engineering polymer solutions, high performance parts, specialty silicones and differentiated adhesive technologies to meet customer specifications in automotive, aerospace, electronics, industrial, healthcare and consumer markets. Transportation & Advanced Polymers is a global leader of advanced materials that provides technologies that differentiate customers’ products with improved performance characteristics.

*In millions*

| Transportation & Advanced Polymers | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $1,355 | $1,425 |
| Operating EBITDA | $414 | $437 |
| Equity earnings | $2 | $3 |

| Transportation & Advanced Polymers Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2019 |
| --- | ---: |
| Local price & product mix | 7% |
| Currency | (3) |
| Volume | (9) |
| Portfolio & other | — |
| Total | (5)% |

Transportation & Advanced Polymers net sales were $1,355 million in the first quarter of 2019, down 5 percent from $1,425 million in the first quarter of 2018. The change in net sales was due to a 7 percent increase in local price which was more than offset by a 9 percent decrease in volume and a 3 percent unfavorable currency impact, primarily in EMEA and Asia Pacific. The increase in local price, primarily in engineering polymers, reflected a tight polymer supply and higher feedstock costs. Volume declines were primarily due to decreased demand in automotive and electronics markets.

Operating EBITDA was $414 million in the first quarter of 2019, down 5 percent from $437 million in the first quarter of 2018 due to pricing gains and cost synergies, which were more than offset by higher raw material costs, volume declines and unfavorable currency impacts.

### SAFETY & CONSTRUCTION

The Safety & Construction segment is a leading provider of engineered products and integrated systems for a number of industries including construction, worker safety, energy, oil and gas, transportation, medical devices and water purification and separation. The segment satisfies the growing global needs of businesses, governments, and consumers for solutions that make life safer, healthier, and better. By uniting market-driven science with the strength of highly regarded brands, the segment strives to bring new products and solutions to solve customers' needs faster, better and more cost effectively. The segment is a leader in safety consulting, selling training products as well as consulting services, to improve the safety, productivity, and sustainability of organizations across a range of industries.

*In millions*

| Safety & Construction | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $1,322 | $1,299 |
| Operating EBITDA | $411 | $354 |
| Equity earnings | $7 | $5 |

| Safety & Construction Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2019 |
| --- | ---: |
| Local price & product mix | 4% |
| Currency | (2) |
| Volume | 4 |
| Portfolio & other | (4) |
| Total | 2% |

Safety & Construction net sales were $1,322 million in the first quarter of 2019, up 2 percent from $1,299 million in the first quarter of 2018. The net sales increase was due to 4 percent volume growth and a 4 percent increase in local price, partially offset by 4 percent unfavorable portfolio actions and a 2 percent unfavorable currency impact. Volume growth in the segment was led by gains across all regions and in water, TYVEK® and KEVLAR® due to broad-based strength in industrial markets and life & personal protection and medical end-markets. These gains were partially offset by declines primarily due to weakness in the U.S. residential market.

Operating EBITDA was $411 million in the first quarter of 2019, up 16 percent compared with $354 million in the first quarter of 2018 due to cost synergies, volume growth and pricing gains, partially offset by higher raw material costs and unfavorable currency impacts.

### CORPORATE

Corporate includes certain enterprise and governance activities (including insurance operations, environmental operations, geographic management, etc.); business incubation platforms; non-business aligned joint ventures; gains and losses on the sales of financial assets; non-business aligned litigation expenses; discontinued or non-aligned businesses and pre-commercial activities.

*In millions*

| Corporate | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Net sales | $71 | $76 |
| Operating EBITDA | $(170) | $(168) |
| Equity losses | $(6) | $(9) |

Net sales for Corporate, which primarily relate to insurance operations, were $71 million in the first quarter of 2019, compared with net sales of $76 million in the first quarter of 2018.

Operating EBITDA was a loss of $170 million in the first quarter of 2019, essentially flat compared with an Operating EBITDA loss of $168 million in the first quarter of 2018.

### SUPPLEMENTAL DIVISION INFORMATION

Discussion of segment revenue, operating EBITDA and price/volume metrics on a divisional basis for Agriculture is based on the results of the Agriculture segment; for Materials Science is based on the combined results of the Performance Materials & Coatings segment, the Industrial Intermediates & Infrastructure segment and the Packaging & Specialty Plastics segment; and for Specialty Products is based on the combined results of the Electronics & Imaging segment, the Nutrition & Biosciences segment, the Transportation & Advanced Polymers segment and the Safety & Construction segment. The Corporate segment is not included in the division metrics. The segment disclosures have been presented in this manner for informational purposes only and should not be viewed as an indication of each division’s current or future operating results on a standalone basis assuming completion of the Intended Business Separations. See the section entitled “Segment Results” for additional qualitative analysis on segment performance.

*In millions*

| Net Sales by Division | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Agriculture | $3,397 | $3,808 |
| Performance Materials & Coatings | 2,255 | 2,304 |
| Industrial Intermediates & Infrastructure | 3,402 | 3,715 |
| Packaging & Specialty Plastics | 5,110 | 6,010 |
| Materials Science | $10,767 | $12,029 |
| Electronics & Imaging | 1,078 | 1,153 |
| Nutrition & Biosciences | 1,659 | 1,720 |
| Transportation & Advanced Polymers | 1,355 | 1,425 |
| Safety & Construction | 1,322 | 1,299 |
| Specialty Products | $5,414 | $5,597 |

| Net Sales Variance by Division Local Price & Product Mix Percent change from prior year | Three Months Ended Mar 31, 2019 Currency | Volume | Portfolio / Other | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: |
| Agriculture | 1% | (5)% | (7)% | —% | (11)% |
| Materials Science | (9)% | (2)% | 1% | —% | (10)% |
| Specialty Products | 3% | (2)% | (3)% | (1)% | (3)% |

*In millions*

| Operating EBITDA by Division | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Agriculture | $667 | $891 |
| Performance Materials & Coatings | 481 | 586 |
| Industrial Intermediates & Infrastructure | 448 | 654 |
| Packaging & Specialty Plastics | 993 | 1,301 |
| Materials Science | $1,922 | $2,541 |
| Electronics & Imaging | 385 | 398 |
| Nutrition & Biosciences | 390 | 418 |
| Transportation & Advanced Polymers | 414 | 437 |
| Safety & Construction | 411 | 354 |
| Specialty Products | $1,600 | $1,607 |

60

### CHANGES IN FINANCIAL CONDITION

The Company had cash and cash equivalents and marketable securities of $11,662 million at March 31, 2019 and $13,616 million at December 31, 2018, of which $5,539 million at March 31, 2019 and $5,820 million at December 31, 2018, was held by subsidiaries in foreign countries, including United States territories. The decrease in cash and cash equivalents held by subsidiaries in foreign countries is due to the repatriation activities discussed below. For each of its foreign subsidiaries, the Company makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States.

The Act requires companies to pay a one-time transition tax on earnings of foreign subsidiaries, a majority of which were previously considered permanently reinvested by the Company (see Note 7 to the Consolidated Financial Statements for further details of The Act). The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. The Company has the ability to repatriate additional funds to the U.S., which could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state income taxes and the impact of foreign currency movements. It is not practicable to calculate the unrecognized deferred tax liability on undistributed foreign earnings due to the complexity of the hypothetical calculation. During the first and second quarters of 2019, in connection with the Intended Business Separations, the Company has and expects to continue repatriating certain funds from its non-U.S. subsidiaries that are not needed to finance local operations or separation activities. During the three months ended March 31, 2019, the Company recorded tax expense of $13 million associated with these repatriation activities.

The Company’s cash flows from operating, investing and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table.

*In millions*

| Cash Flow Summary Cash provided by (used for): | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Operating activities | $26 | $(2,137) |
| Investing activities | (1,000) | 290 |
| Financing activities | (1,032) | (1,543) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 50 | 208 |
| Summary |  |  |
| Decrease in cash, cash equivalents and restricted cash | $(1,956) | $(3,182) |
| Cash, cash equivalents and restricted cash at beginning of period | 14,022 | 14,015 |
| Cash, cash equivalents and restricted cash at end of period | $12,066 | $10,833 |
| Less: Restricted cash and cash equivalents, included in "Other current assets" | 523 | 552 |
| Cash and cash equivalents at end of period | $11,543 | $10,281 |

#### Cash Flows from Operating Activities

In the first three months of 2019, cash provided by operating activities was $26 million, compared with cash used for operating activities of $2,137 million in the same period last year. The increase in cash was primarily due to a decrease in cash used for working capital, higher prepayments from customer contracts, increased dividend payments received from nonconsolidated affiliates, lower pension contributions and lower tax payments.

*In millions*

| Net Working Capital | Mar 31, 2019 | Dec 31, 2018 |
| --- | ---: | ---: |
| Current assets | $49,248 | $49,603 |
| Current liabilities | 28,580 | 24,715 |
| Net working capital | $20,668 | $24,888 |
| Current ratio | 1.72:1 | 2.01:1 |

#### Cash Flows from Operating Activities - Non-GAAP

The following table reconciles cash flows from operating activities to a non-GAAP measure regarding cash flows from operating activities excluding the impact of Accounting Standards Update ("ASU") 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments" and related interpretive guidance for the three months ended March 31, 2018. Management believes this non-GAAP financial measure is relevant and meaningful as it presents cash flows from operating activities inclusive of all trade accounts receivable collection activity, which the Company utilizes in support of its operating activities.

*In millions*

| Cash Flows from Operating Activities Excluding the Impact of ASU 2016-15 and Additional Interpretive Guidance (non-GAAP) | Three Months Ended Mar 31, 2018 |
| --- | ---: |
| Cash flows from operating activities - Updated for impact of ASU 2016-15 and additional interpretive guidance (GAAP) | $(2,137) |
| Less: Impact of ASU 2016-15 and additional interpretive guidance | 445 |
| Cash flows from operating activities - Excluding impact of ASU 2016-15 and additional interpretive guidance (non-GAAP) | $(1,692) |

#### Cash Flows from Investing Activities

In the first three months of 2019, cash used for investing activities was $1,000 million, reflecting capital expenditures and purchases of investments, which were partially offset by proceeds from sales and maturities of investments. In the first three months of 2018, cash provided by investing activities was $290 million, reflecting proceeds from sales and maturities of investments and proceeds from interests in trade accounts receivable conduits, which were partially offset by capital expenditures and purchases of investments. Capital spending was $1,139 million in the first three months of 2019, compared with $776 million in the first three months of 2018.

#### Cash Flows from Financing Activities

In the first three months of 2019, cash used for financing activities was $1,032 million compared with $1,543 million in the same period last year. The decrease was primarily due to an increase of proceeds from issuance of long-term debt, net of payments and an increase in notes payable, which were partially offset by an increase in purchases of treasury stock.

### Free Cash Flow

The Company defines free cash flow as cash from operating activities less capital expenditures. Under this definition, free cash flow represents the cash generated by the Company from operations after investing in its asset base. Free cash flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free cash flow is an integral financial measure used in the Company's financial planning process. This financial measure is not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP financial measures of performance. All companies do not calculate non-GAAP financial measures in the same manner and, accordingly, the Company's free cash flow definition may not be consistent with the methodologies used by other companies.

For additional information relating to the change in cash used for operating activities, see the discussion in the previous section entitled "Cash Flows from Operating Activities."

*In millions*

| Reconciliation of "Cash From Operating Activities" to Free Cash Flow (non-GAAP) | Three Months Ended Mar 31, 2019 | Mar 31, 2018 |
| --- | ---: | ---: |
| Cash from operating activities (GAAP) | $26 | $(2,137) |
| Capital expenditures | (1,139) | (776) |
| Free cash flow (non-GAAP) | $(1,113) | $(2,913) |

### Liquidity & Financial Flexibility

The Company’s primary source of incremental liquidity is cash flows from operating activities. Management expects the generation of cash from operations and the ability to access the debt capital markets and other sources of liquidity will continue to provide sufficient liquidity and financial flexibility to meet the Company’s and its subsidiaries obligations as they come due.

### DowDuPont's Liquidity Sources

In November 2018, DowDuPont consummated the offering of the senior unsecured notes (the "DowDuPont Notes") in an aggregate principal amount of $12.7 billion. The offering consisted of $0.5 billion in floating rate notes due November 2020, $0.3 billion in floating rate notes due November 2023, and six tranches of fixed-rate notes: $1.5 billion due November 2020, $2.5 billion due November 2023, $1.85 billion due November 2025, $2.25 billion due November 2028, $1.65 billion due November 2038 and $2.15 billion due November 2048. The net proceeds of the offering after the underwriting discount was $12.6 billion. See Note 13 to the Consolidated Financial Statements for additional information on the interest related to the DowDuPont Notes.

The DowDuPont Notes will rank equally with the Company's future senior unsecured debt outstanding from time to time. The DowDuPont Notes are not guaranteed by any of the Company's subsidiaries and are nonrecourse to the assets of Dow and Corteva. Each series of DowDuPont Notes will continue to be a senior unsecured obligation of DuPont after the separations and distributions. If each of the separations and distributions has not been completed on or before May 1, 2020, or, if prior to such date, the Company has abandoned any of the separations or distributions, the Company will be required to redeem each series of DowDuPont Notes at a redemption price equal to 101 percent of the principal amount of such series of DowDuPont Notes, plus accrued and unpaid interest, if any, up to but excluding the date of redemption.

On April 1, 2019 prior to consummating the Dow Distribution, the Company contributed $2,024 million to Dow. The remaining proceeds from the DowDuPont Notes will be used to (i) reduce outstanding liabilities of Historical DuPont that would otherwise be attributed to Corteva; and (ii) further pay any related premiums, fees and expenses.

#### Term Loan and Revolving Credit Facilities - DowDuPont

In November 2018, the Company entered into a term loan agreement that establishes two term loan facilities in the aggregate principal amount of $3 billion, (the “DowDuPont Term Loan Facilities”) as well as a five-year $3 billion revolving credit facility (the “DowDuPont RCF”), availability of funding for each being subject to the satisfaction or waiver or certain customary conditions, including among others the consummation of the Dow Distribution. As of March 31, 2019, the DowDuPont Term Loan Facilities and DowDuPont RCF were unfunded and not yet available. The Company amended the DowDuPont RCF to become available as of May 2, 2019. The DowDuPont RCF is intended to remain unfunded.

Effective May 2, 2019, the Company fully drew the two DowDuPont Term Loan Facilities in the aggregate principal amount of $3.0 billion.

#### Commercial Paper - DowDuPont

In April 2019, DowDuPont authorized a $3 billion commercial paper program (the “DowDuPont Commercial Paper Program”), to become available concurrent with the DowDuPont RCF. The DowDuPont Commercial Paper Program, along with other primary sources of liquidity including cash from operations and cash and cash equivalents balances, is intended to fund the Company’s liquidity needs, including anticipated cash requirements related to working capital, capital spending, dividend payments, debt maturities and other cash needs.

#### Credit Ratings - DowDuPont

Coincident with the DowDuPont notes offering in November 2018, the credit rating agencies released credit ratings for DowDuPont, prospectively assuming the consummation of the separations and distributions of Dow and Corteva. The ratings for the Company are: A- with a Stable outlook from Standard & Poor’s; Baa1 with a Stable outlook from Moody’s Investors Service; and BBB+ with a Stable outlook from Fitch Ratings.

### Historical DuPont's Liquidity Sources

#### Commercial Paper - Historical DuPont

Historical DuPont issues promissory notes under U.S. commercial paper programs. At March 31, 2019, Historical DuPont had $2,588 million of commercial paper outstanding ($1,847 million at December 31, 2018). Historical DuPont maintains access to the commercial paper market at competitive rates. Amounts outstanding under Historical DuPont's commercial paper programs during the period may be greater, or less, than the amount reported at the end of the period.

#### Committed Credit Facilities - Historical DuPont

In the event the Company has short-term liquidity needs, it can access liquidity through Historical DuPont's committed and available credit facilities. At March 31, 2019, Historical DuPont had total committed credit facilities of $8.8 billion with remaining available credit facilities of $5.7 billion. See Note 15 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018, for additional information on committed and available credit facilities.

#### Term Loan and Revolving Credit Facilities - Historical DuPont

In March 2016, Historical DuPont entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as may be amended, from time to time, the "Historical DuPont Term Loan Facility") under which Historical DuPont may make up to seven term loan borrowings and amounts repaid or prepaid are not available for subsequent borrowings. The proceeds from the borrowings under the Term Loan Facility will be used for Historical DuPont's general corporate purposes including debt repayment, working capital and funding a portion of the Company's costs and expenses. The Term Loan Facility was amended in 2018 to extend the maturity date to June 2020, at which time all outstanding borrowings, including accrued but unpaid interest, become immediately due and payable, and to extend the date on which the commitment to lend terminates to June 2019. At March 31, 2019, Historical DuPont had made six term loan borrowings in an aggregate principal amount of $3.0 billion and had unused commitments of $1.5 billion under the Term Loan Facility. In addition, in 2018, Historical DuPont amended its $3.0 billion revolving credit facility to extend the maturity date to June 2020.

On May 2, 2019 Historical DuPont terminated its Term Loan Facility ("the Termination") and repaid the aggregate outstanding principal amount of $3 billion plus accrued and unpaid interest through and including May 1, 2019.

In November 2018, Historical DuPont entered into a $3.0 billion five-year revolving credit facility and a $3.0 billion three-year revolving credit facility (the “2018 Revolving Credit Facilities”). Availability of funds was subject to a number of conditions, including Corteva becoming a party to the 2018 Revolving Credit Facilities and the consummation of the separation and distribution of Corteva. On May 2, 2019, the 2018 Revolving Credit Facilities were amended, making the 2018 Revolving Credit Facilities available for Historical DuPont, effective May 2, 2019. Corteva will become a party to the 2018 Revolving Credit Facilities upon the separation and distribution from DowDuPont. The 2018 Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings and generally consistent with those applicable to Historical DuPont’s existing term loan and revolving credit facilities. The 2018 Revolving Credit Facilities also contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Historical DuPont and its consolidated subsidiaries not exceed 0.60.

#### Committed Receivable Repurchase Facility - Historical DuPont

In February 2019, in line with seasonal agricultural working capital requirements, Historical DuPont entered into a committed receivable repurchase agreement of up to $1.3 billion (the "2019 Repurchase Facility") which expires in December 2019. From time to time, Historical DuPont and the banks modify the monthly commitment amounts to better align with working capital requirements. Under the 2019 Repurchase Facility, Historical DuPont may sell a portfolio of available and eligible outstanding customer notes receivables within the Agriculture segment to participating institutions and simultaneously agree to repurchase at a future date. See Note 13 to the Consolidated Financial Statements for additional information.

#### Credit Ratings - Historical DuPont

At April 30, 2019, Historical DuPont's credit ratings were: A- for a long-term rating and A-2 for a short-term rating with a Stable outlook from Standard & Poor’s; A3 for a long-term rating and P-2 for a short-term rating with a Stable outlook from Moody’s Investors Service; and A for a long-term rating and F1 for a short-term rating with a Stable outlook from Fitch Ratings. Downgrades in Historical DuPont's credit ratings would increase borrowing costs on certain indentures and could impact its ability to access debt capital markets.

### Debt

The Company’s public debt instruments and primary, private credit agreements (collectively "Debt Instruments") reside with DowDuPont, as well as Historical Dow and Historical DuPont (together, the "Subsidiaries"). See Note 13 to the Consolidated Financial Statements for information related to the Subsidiaries' notes payable and long-term debt activity since December 31, 2018, including debt retired and issued. The following table reflects the debt of DowDuPont and the Subsidiaries:

*In millions*

| Total Debt | Mar 31, 2019 DowDuPont1 | Historical Dow | Historical DuPont | Total | Dec 31, 2018 DowDuPont1 | Historical Dow | Historical DuPont | Total |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Notes payable | $— | $317 | $2,678 | $2,995 | $— | $302 | $1,863 | $2,165 |
| Long-term debt due within one year | — | 2,369 | 1,640 | 4,009 | — | 340 | 297 | 637 |
| Long-term debt | 12,599 | 17,160 | 5,207 | 34,966 | 12,596 | 19,254 | 5,812 | 37,662 |
| Total debt | $12,599 | $19,846 | $9,525 | $41,970 | $12,596 | $19,896 | $7,972 | $40,464 |

1\. Represents the DowDuPont holding company.

On November 13, 2018, Historical DuPont launched a tender offer (the “Tender Offer”) to purchase $6.2 billion aggregate principal amount of its outstanding debt securities (the “Tender Notes”). The Tender Offer expired on December 11, 2018 (the “Expiration Date”). At the Expiration Date, $4,409 million aggregate principal amount of the Tender Notes had been validly tendered and was accepted for payment. In exchange for such validly tendered Tender Notes, Historical DuPont paid a total of $4,849 million, which included breakage fees and all applicable accrued and unpaid interest on such Tender Notes. DowDuPont contributed cash (generated from the offering of the DowDuPont Notes) to Historical DuPont to fund the settlement of the Tender Offer and payment of associated fees.

On March 22, 2019, Historical DuPont issued notices of redemption in full of all of its outstanding notes (the “Make Whole Notes”) listed in the table below:

*(in millions)*

|  | Amount |
| --- | ---: |
| 4.625% Notes due 2020 | $474 |
| 3.625% Notes due 2021 | 296 |
| 4.250% Notes due 2021 | 163 |
| 2.800% Notes due 2023 | 381 |
| 6.500% Debentures due 2028 | 57 |
| 5.600% Senior Notes due 2036 | 42 |
| 4.900% Notes due 2041 | 48 |
| 4.150% Notes due 2043 | 69 |
| Total | $1,530 |

The Make Whole Notes were redeemed on April 22, 2019, at the make-whole redemption prices set forth in the respective Make Whole Notes. On and after the date of redemption, the Make Whole Notes were no longer deemed outstanding, interest on the Make Whole Notes ceased to accrue and all rights of the holders of the Make Whole Notes were terminated.

In connection with the expected announcement of the record date for the intended Corteva Distribution, Historical DuPont will be required to mail a notice of redemption to holders of the $1,250 million aggregate principal amount of 2.200 percent Notes due 2020 and $750 million aggregate principal amount of Floating Rate Notes due 2020 (collectively, the “SMR Notes”) setting forth the date of redemption of the SMR Notes. On the date of redemption, Historical DuPont will be required to redeem all of the SMR Notes at a redemption price equal to 100 percent of the aggregate principal amount of the SMR Notes plus accrued and unpaid interest, if any, up to but excluding the date of redemption. Following the redemption, the SMR Notes will no longer be outstanding and will cease to bear interest and all rights of the holders of the SMR Notes will terminate.

The Company expects to finance Historical DuPont’s redemption of the SMR Notes with cash from operations and the remaining proceeds from both the DWDP Term Loan Facilities and DowDuPont Notes, as well as other sources of liquidity. To achieve the intended credit profiles of Corteva and DuPont, DowDuPont expects to further de-lever Historical DuPont prior to the Corteva Distribution. In connection with both of these actions, the Company expects to issue commercial paper in the second quarter 2019. The final amount of the Company’s commercial paper issuance will depend on a number of factors including results of operations, market conditions and capital structure considerations.

### Covenants and Default Provisions

The Company's indenture covenants include customary limitations on liens, sale and leaseback transactions, and mergers and consolidations, subject to certain limitations. The DowDuPont Notes also contain customary default provisions. In addition, the Company will be required to redeem all of the DowDuPont Notes at a redemption price equal to 101 percent of the principal amount of such series of DowDuPont Notes, plus accrued and unpaid interest to, but excluding, the redemption date if each of the separations and distributions has not been completed on or before May 1, 2020, or, if prior to such date, DowDuPont has abandoned the intended Corteva Distribution.

The Debt Instruments of the Subsidiaries contain, among other provisions, certain customary restrictive covenant and default provisions. Historical Dow’s Revolving Credit Agreement contains a financial covenant that Historical Dow must maintain its ratio of consolidated indebtedness to its consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under Historical Dow’s Revolving Credit Agreement equals or exceeds $500 million. The ratio of Historical Dow’s consolidated indebtedness to its consolidated capitalization was 0.41 to 1.00 at March 31, 2019. Historical DuPont’s Term Loan Facility and RCF contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Historical DuPont and its consolidated subsidiaries not exceed 0.6667 to 1.00. At March 31, 2019, management believes each of the Subsidiaries were in compliance with all of their respective covenants and default provisions. For additional information on the Subsidiaries' debt covenants and default provisions, see Note 15 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.

### Dividends

On February 14, 2019, the Company announced that its Board declared a dividend of $0.38 per share, paid on March 15, 2019, to shareholders of record on February 28, 2019. On March 8, 2019, the Company announced that its Board declared a dividend of $325 million ($0.14 per share) in the aggregate on a pro rata basis, payable on May 28, 2019, to shareholders of record on April 26, 2019.

### Share Repurchase Programs

On November 1, 2018, the Company announced a new $3.0 billion share buyback program. The Company spent $1.4 billion in the fourth quarter of 2018 and spent the remaining $1.6 billion in the first quarter of 2019, thereby completing this share repurchase program.

See Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds, for additional information.

### Pension Plans

DowDuPont expects to make additional contributions in the aggregate of about $500 million by year-end 2019 to its pension plans other than the principal U.S. pension plan. Any such contribution could be funded by existing cash balances and/or cash from other available sources of liquidity.

### Restructuring

#### DowDuPont Cost Synergy Program

The activities related to the Synergy Program are expected to result in additional cash expenditures of approximately $650 million to $700 million, primarily by the end of 2019, consisting of severance and related benefit costs and costs associated with exit and disposal activities, including environmental remediation (see Note 5 to the Consolidated Financial Statements). The Company expects to incur additional costs in the future related to its restructuring activities. Future costs are expected to include demolition costs related to closed facilities and restructuring plan implementation costs; these costs will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits, related to its other optimization activities. These costs cannot be reasonably estimated at this time.

### Contractual Obligations

Information related to the Company’s contractual obligations, commercial commitments and expected cash requirements for interest can be found in the Company's 2018 Annual Report on Form 10-K, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources. Additional information related to these obligations can be found in Notes 15, 16 and 19 to the Consolidated Financial Statements in the Company’s 2018 Annual Report on Form 10-K. With the exception of increased borrowings under the Historical DuPont Term Loan Facility, in the first quarter of 2019, there have been no material changes in the Company's contractual obligations since December 31, 2018. See Note 13 to the interim Consolidated Financial Statements for further discussion of the Historical DuPont Term Loan Facility.

### Off-balance Sheet Arrangements

Off-balance sheet arrangements are obligations the Company has with nonconsolidated entities related to transactions, agreements or other contractual arrangements. The Company holds variable interests in joint ventures accounted for under the equity method of accounting. The Company is not the primary beneficiary of these joint ventures and therefore is not required to consolidate the entities (see Note 22 to the Consolidated Financial Statements).

Guarantees arise in the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Subsidiaries undertake an obligation to guarantee the performance of others if specific triggering events occur. The Subsidiaries had combined outstanding guarantees at March 31, 2019, of $4,753 million, compared with $4,778 million at December 31, 2018. Additional information related to the guarantees of the Subsidiaries can be found in the “Guarantees” section of Note 14 to the Consolidated Financial Statements.

### Fair Value Measurements

See Note 21 to the Consolidated Financial Statements for additional information concerning fair value measurements.

### OTHER MATTERS

### Recent Accounting Guidance

See Note 2 to the Consolidated Financial Statements for a summary of recent accounting guidance.

### Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note 1 to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 (“2018 10-K”) describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. DowDuPont’s accounting policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s 2018 10-K. Since December 31, 2018, there have been no material changes in the Company’s accounting policies that are impacted by judgments, assumptions and estimates. See the discussion in this section for information regarding the valuation of assets and impairment considerations.

### Asbestos-Related Matters of Union Carbide Corporation

Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. ("Amchem"). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

The table below provides information regarding asbestos-related claims pending against Union Carbide and Amchem based on criteria developed by Union Carbide and its external consultants.

| Asbestos-Related Claim Activity | 2019 | 2018 |
| --- | ---: | ---: |
| Claims unresolved at Jan 1 | 12,780 | 15,427 |
| Claims filed | 1,383 | 1,932 |
| Claims settled, dismissed or otherwise resolved | (1,569) | (3,026) |
| Claims unresolved at Mar 31 | 12,594 | 14,333 |
| Claimants with claims against both Union Carbide and Amchem | (4,509) | (5,148) |
| Individual claimants at Mar 31 | 8,085 | 9,185 |

Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. In fact, there are no personal injury cases in which only Union Carbide and/or Amchem are the sole named defendants. For these reasons and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.

For additional information, see Asbestos-Related Matters of Union Carbide Corporation in Note 14 to the Consolidated Financial Statements and Part II, Item 1. Legal Proceedings.

### Valuation of Assets and Impairment Considerations

As a result of the Merger and related acquisition method of accounting, Historical DuPont’s assets and liabilities were measured at fair value, and any declines in the projected cash flows could have a material, negative impact on the fair value of the Company’s reporting units and assets, particularly within the Agriculture and Specialty Products divisions, and therefore could result in an impairment.

In preparation for the intended Corteva Distribution, Historical DuPont completed the separation of the assets and liabilities related to its specialty products businesses (the “Historical DuPont Net SP Assets”) into separate legal entities. On May 1, 2019, Historical DuPont distributed those legal entities to DowDuPont (the “Internal SP Distribution”). The Internal SP Distribution triggers a re-assessment at the Historical DuPont level of the recoverability of goodwill and the overall carrying value of the Historical DuPont Net SP Assets.

In connection with the consummation of the intended Corteva Distribution, DowDuPont will assess the recoverability of the goodwill and the overall carrying value of the net assets of its agriculture business. In connection with DowDuPont’s Second Quarter Segment Realignments, the Company will reassess and may re-define its reporting units. See the Overview section of the MD&A for more information about the Second Quarter Segment Realignments.

Two of the Company’s current reporting units, Industrial Biosciences and Clean Technologies, are comprised solely of Historical DuPont assets and liabilities, the carrying values of which were measured at fair value in connection with the Merger. These reporting units are considered at risk for impairment given the small margin of their respective fair values over their respective carrying values as of the date of the Company’s last annual impairment test. In addition, recent unfavorable market conditions slowed demand in the biomaterials business unit in Industrial Biosciences. The carrying amount of goodwill for the Industrial Biosciences and Clean Technologies reporting units at March 31, 2019 was $3,100 million and $461 million, respectively. As part of the Second Quarter Segment Realignments, the biomaterials business unit in Industrial Biosciences and the Clean Technologies reporting unit will be included in the Non-Core segment effective June 1, 2019.

DowDuPont will assemble and review updated financial projections, including any changes to key assumptions, in connection with the Internal SP Distribution, intended Corteva Distribution and Second Quarter Segment Realignments. In connection with this activity, the outcome of which is not currently known, it is possible that non-cash impairment charges could be recorded in second quarter 2019. There can be no assurance that such charges, if any, would not be material to the Company.

## Market risk

As filed, 316 characters.

See Note 20 to the Consolidated Financial Statements. See also Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk, of the Company's 2018 Annual Report on Form 10-K for information on the Company's utilization of financial instruments and an analysis of the sensitivity of these instruments.

## Controls and procedures

As filed, 1,576 characters.

### Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company carried out an evaluation, under the supervision and with the participation of the Company’s Disclosure Committee and the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.

### Changes in Internal Control Over Financial Reporting

There were no changes in the Company's internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

In connection with the Dow Distribution and the intended Corteva Distribution, there are several processes, policies, operations, technologies and information systems that were integrated following the Merger which have been or will be replicated, transferred or separated. The Company continues to take steps to ensure that adequate controls are designed and maintained throughout this transition period.

### DowDuPont Inc. PART II - OTHER INFORMATION

## Risk factors

As filed, 2,107 characters.

**Inability to access the debt capital markets could impair DowDuPont's liquidity, business or financial condition.**

DowDuPont’s primary sources of liquidity to finance operations, including dividends on its common stock, are cash through operations, including those conducted through its subsidiaries, including Historical DuPont, DowDuPont’s direct access to the debt capital markets, and through Historical DuPont’s access to the debt capital markets. In addition, Historical DuPont has relied and continues to rely on access to the debt capital markets to finance day-to-day and long-term operations. Any limitation on the Company’s ability to raise money in the debt markets could have a substantial negative effect on liquidity. Access to the debt capital markets could be impaired as a result of the existence of material nonpublic information about the intended Corteva Distribution and other potential factors, including factors that are not specific to the Company and its subsidiaries, such as a severe disruption of the financial markets and interest rate fluctuations.

Prior to the intended Corteva Distribution, the level and quality of the respective earnings, operations, business and management, among other things, of Historical DuPont will impact its credit ratings, costs and availability of financing and those of the combined Company. A decrease in the ratings assigned to DowDuPont or Historical DuPont by the ratings agencies may negatively impact access to the debt capital markets and increase the Company’s cost of borrowing. There can be no assurance that DowDuPont and Historical DuPont will maintain their current credit worthiness or prospective credit ratings. Any actual or anticipated changes or downgrades in such credit ratings may have a negative impact on the liquidity, capital position or access to capital markets.

A detailed discussion of additional significant risks and uncertainties which may cause results and events to differ materially from is included in the section titled “Risk Factors” (Part I, Item 1A) of DowDuPont’s 2018 Annual Report on Form 10-K.

Filed May 3, 2019.
Source: SEC EDGAR, the filing index for accession 0001666700-19-000019. Last ingested by Listed: Nov 10, 2026, 16:51 ET. No prices; not investment advice.
